IdentificationGeneric Name(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-oneDrugBank Accession NumberDB07430BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one (DB07430)× CloseWeightAverage: 374.459 Monoisotopic: 374.120131908 Chemical FormulaC21H18N4OSSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUMAP kinase-activated protein kinase 2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyridines and derivativesSub ClassBipyridines and oligopyridinesDirect ParentBipyridines and oligopyridinesAlternative ParentsThienodiazepines / Quinolines and derivatives / 1-benzothiophenes / 2-heteroaryl carboxamides / 1,4-diazepines / Methylpyridines / Secondary alkylarylamines / Benzenoids / Vinylogous amides / Heteroaromatic compounds / Thiophenes / Lactams / Amino acids and derivatives / Secondary carboxylic acid amides / Azacyclic compounds / Organooxygen compounds / Organic oxides / Hydrocarbon derivatives / Organopnictogen compounds


 show 9 moreSubstituents1-benzothiophene / 2-heteroaryl carboxamide / Amine / Amino acid or derivatives / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Benzothiophene / Bipyridine / Carboxamide group / Carboxylic acid derivative / Heteroaromatic compound / Hydrocarbon derivative / Lactam / Methylpyridine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Para-diazepine / Quinoline / Secondary aliphatic/aromatic amine / Secondary amine / Secondary carboxylic acid amide / Thieno-para-diazepine / Thiophene / Vinylogous amide


 show 19 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyCMWRPDHVGMHLSZ-GFCCVEGCSA-NInChIInChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1IUPAC Name(15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.0^{2,7}.0^{12,18}]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-oneSMILES[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound44631903PubChem Substance99443901ChemSpider25058556BindingDB50395272ChEMBLCHEMBL1231206ZINCZINC000039258365PDBe LigandB97PDB Entries3fyj / 6t8x / 7nryClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00153 mg/mLALOGPSlogP3.86ALOGPSlogP3.53ChemaxonlogS-5.4ALOGPSpKa (Strongest Acidic)15.79ChemaxonpKa (Strongest Basic)5ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area66.91 Å2ChemaxonRotatable Bond Count1ChemaxonRefractivity106.92 m3·mol-1ChemaxonPolarizability41.3 Å3ChemaxonNumber of Rings5ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9964Blood Brain Barrier+0.9272Caco-2 permeable-0.5609P-glycoprotein substrateSubstrate0.671P-glycoprotein inhibitor INon-inhibitor0.7103P-glycoprotein inhibitor IINon-inhibitor0.9621Renal organic cation transporterNon-inhibitor0.8144CYP450 2C9 substrateNon-substrate0.7342CYP450 2D6 substrateNon-substrate0.7749CYP450 3A4 substrateSubstrate0.6195CYP450 1A2 substrateInhibitor0.8217CYP450 2C9 inhibitorNon-inhibitor0.5606CYP450 2D6 inhibitorNon-inhibitor0.7565CYP450 2C19 inhibitorInhibitor0.6308CYP450 3A4 inhibitorNon-inhibitor0.6672CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.6697Ames testNon AMES toxic0.6855CarcinogenicityNon-carcinogens0.876BiodegradationNot ready biodegradable1.0Rat acute toxicity2.3178 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9987hERG inhibition (predictor II)Inhibitor0.5791  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)5N/AN/AA29807


 Details


 Binding Properties1. MAP kinase-activated protein kinase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionSignal transducer activitySpecific FunctionStress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA dam...Gene NameMAPKAPK2Uniprot IDP49137Uniprot NameMAP kinase-activated protein kinase 2Molecular Weight45567.415 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52 